TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/11/18 16:30 | 10/10/18 | HSGX | Histogenics Corp | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Rakin Kevin | MA | D | P.d | 0 | 0.00 | 0 | 231 | 101 | 459 | D | |||||||||||||||
12/8/14 16:45 | 12/8/14 | HSGX | Histogenics Corp | DE | Health | Orthop | Orthopedic, Prosthetic & Surg | Rakin Kevin | MA | D | P.d | 124 | 11.00 | 0 | 11 | 15 | 86 | M | |||||||||||||||
3/28/08 14:27 | 3/26/08 | OMRI | Omrix Biopharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Rakin Kevin | NY | D | P | 27 | 13.65 | 0 | 2 | 100 | 4 | D | |||||||||||||||
3/15/07 11:48 | 3/13/07 | VION | Vion Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Rakin Kevin | CT | D | P | 24 | 1.59 | 0 | 15 | 43 | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |